ZAGNI, Irene
 Distribuzione geografica
Continente #
NA - Nord America 883
EU - Europa 597
AS - Asia 207
OC - Oceania 2
SA - Sud America 2
Totale 1.691
Nazione #
US - Stati Uniti d'America 883
GB - Regno Unito 228
CN - Cina 201
SE - Svezia 78
IE - Irlanda 77
FR - Francia 67
DE - Germania 57
FI - Finlandia 40
IT - Italia 25
UA - Ucraina 15
RO - Romania 3
AT - Austria 2
IN - India 2
NL - Olanda 2
TR - Turchia 2
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
CL - Cile 1
IR - Iran 1
KR - Corea 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RU - Federazione Russa 1
Totale 1.691
Città #
Southend 197
Chandler 184
Jacksonville 182
Woodbridge 95
Houston 80
Dublin 77
Ashburn 52
Ann Arbor 49
Nanjing 30
Wilmington 29
Jinan 27
New York 27
Lawrence 23
Princeton 23
Shenyang 23
Lancaster 20
Sindelfingen 18
Helsinki 15
Haikou 13
Hebei 13
Tianjin 12
Beijing 9
Nanchang 9
Rome 9
Hangzhou 8
Boardman 7
Changsha 6
Jiaxing 6
Ningbo 6
Taiyuan 6
Taizhou 6
Verona 6
Milan 5
Zhengzhou 5
Falls Church 4
Lanzhou 4
Guangzhou 3
Leawood 3
Nürnberg 3
Qingdao 3
San Mateo 3
Seattle 3
Auburn Hills 2
Bangalore 2
Chicago 2
Edinburgh 2
Ficarazzi 2
Norwalk 2
San Diego 2
Timisoara 2
Washington 2
Ardabil 1
Auckland 1
Augusta 1
Canberra 1
Fairfield 1
Gangdong-gu 1
Mehlingen 1
Monmouth Junction 1
Oklahoma City 1
Provo 1
Redwood City 1
San Francisco 1
Sofia 1
São Paulo 1
Vienna 1
Warsaw 1
Totale 1.337
Nome #
Accuracy of ultrasound in the detection of liver fibrosis in chronic viral hepatitis. 120
Hepatitis C virus genotype and prognosis of compensated cirrhosis type C 93
Effect of hepatitis B and C virus infection on the natural history of compensated cirrhosis: a cohort study of 297 patients. 85
Consensus interferon (CIFN) in combination with ribavirin (RBV) for naive patients with chronic hepatitis C: a multicenter study 84
A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone. 81
Influence of hepatitis delta virus infection on clinical outcome of compensated cirrhosis type B 80
Efficacy of prolonged 5 million units of interferon in combination with ribavirin for relapser patients with chronic hepatitis C. 77
A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C. 77
Hepatocellularcarcinoma in cirrhosis: incidence and risk factors. 73
Natural course and prognostic factors of hepatitis B. 71
Natural history of hepatitis B virus infection and disease 70
Efficacy of prolonged high dose of interferon (IFN) plus ribavirin in young genotype 1/4 patients with chronic hepatitis C not responding to IFN alone 70
Incidenza e fattori di rischio di epatocarcinoma. 69
Efficacy and safety of consensus interferon (CIFN) plus ribavirin (RBV) for naive patients with chronic hepatitis C (CHC): final report of a pilot study 69
Natural history of hepatitis B and prognostic factors of disease progression 68
Interferon (IFN) induction followed by prolonged high dose IFN in combination with ribavirin (RBV) for relapsers HCV patients: a randomized controlled multicenter trial 68
Hepatocellular carcinoma in cirrhosis:incidence and risk factors 67
Antifibrogenic effect of combination interferon plus ribavirin treatment in patients with chronic hepatitis C 67
Final report of a consensus interferon (CIFN) plus ribavirin (RBV) study for chronic hepatitis C (CHC) 66
The risk of hepatocellular carcinoma (HCC) among patients with cirrhosis 64
Storia naturale della epatite cronica e cirrosi da virus C. 61
Efficacy of consensus interferon (CIFN) plus ribavirin (RBV) as initial treatment for chronic hepatitis C patients: an italian multicentre study 57
The risk of hepatocellular carcinoma (HCC) in cirrhosis 56
Totale 1.693
Categoria #
all - tutte 4.702
article - articoli 1.528
book - libri 0
conference - conferenze 2.385
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 789
Totale 9.404


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 5 1 3
2019/2020204 33 2 0 23 1 18 24 23 7 26 6 41
2020/2021214 14 42 35 15 15 19 0 23 15 0 33 3
2021/2022163 10 43 1 3 26 5 2 10 11 3 8 41
2022/2023448 33 64 40 92 32 98 7 23 42 3 9 5
2023/2024169 8 12 19 44 39 39 4 2 0 2 0 0
Totale 1.693